会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • GENES DIFFERENTIALLY EXPRESSED BY CUMULUS CELLS AND ASSAYS USING SAME TO IDENTIFY PREGNANCY COMPETENT OOCYTES
    • 由细胞表达的基因和使用相同的鉴定蛋白质测定蛋白质的测定
    • WO2011060080A2
    • 2011-05-19
    • PCT/US2010/056252
    • 2010-11-10
    • GEMA DIAGNOSTICS, INC.CIBELLI, Jose, B.IAGER, Amy, E.OTU, Hasan, H.
    • CIBELLI, Jose, B.IAGER, Amy, E.OTU, Hasan, H.
    • G01N33/689C12Q1/6881C12Q2600/158G01N2800/52
    • A genetic means of identifying "pregnancy competent" oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the "pregnancy signature", also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g. , pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. In preferred embodiments the pregnancy signature will comprise one or more of ABCA6, NCAM1, OLFML3, PTPRA, SDF4, GPR137B, DDIT4, DUSP1, GPR137B, IDUA, KCTD5, NDNL2, SLC26A3, and TERF2IP.
    • 提供了鉴定“怀孕能力”卵母细胞的遗传方式。 该方法包括检测在来自怀孕感染性卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫疾病等。 在优选实施方案中,怀孕签名将包括ABCA6,NCAM1,OLFML3,PTPRA,SDF4,GPR137B,DDIT4,DUSP1,GPR137B,IDUA,KCTD5,NDNL2,SLC26A3和TERF2IP中的一种或多种。
    • 3. 发明申请
    • GENES DIFFERENTIALLY EXPRESSED BY CUMULUS CELLS AND ASSAYS USING SAME TO IDENTIFY PREGNANCY COMPETENT OOCYTES
    • 基因差异表达的细胞和使用相同的方法来鉴定妊娠期卵母细胞
    • WO2011060080A3
    • 2011-11-17
    • PCT/US2010056252
    • 2010-11-10
    • GEMA DIAGNOSTICS INCCIBELLI JOSE BIAGER AMY EOTU HASAN H
    • CIBELLI JOSE BIAGER AMY EOTU HASAN H
    • C12Q1/68C12N5/075C12N15/12G01N33/15
    • G01N33/689C12Q1/6881C12Q2600/158G01N2800/52
    • A genetic means of identifying "pregnancy competent" oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the "pregnancy signature", also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. In preferred embodiments the pregnancy signature will comprise one or more of ABCA6, NCAM1, OLFML3, PTPRA, SDF4, GPR137B, DDIT4, DUSP1, GPR137B, IDUA, KCTD5, NDNL2, SLC26A3, and TERF2IP.
    • 提供了识别“怀孕的”卵母细胞的遗传手段。 该手段包括检测一个或多个基因的表达水平,所述基因在源自怀孕感受性卵母细胞的卵丘细胞中以特征性水平(上调或下调)表达。 这种特征性基因表达水平或本文称为“妊娠特征”的模式也可用于鉴定具有潜在病症的个体,所述个体具有损害或预防活的怀孕的发展,例如绝经前期病症,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖疾病,自身免疫性疾病等。 在优选的实施方案中,妊娠签名将包括ABCA6,NCAM1,OLFML3,PTPRA,SDF4,GPR137B,DDIT4,DUSP1,GPR137B,IDUA,KCTD5,NDNL2,SLC26A3和TERF2IP中的一种或多种。
    • 4. 发明申请
    • GENES DIFFERENTIALLY EXPRESSED BY CUMULUS CELLS AND ASSAYS USING SAME TO IDENTIFY PREGNANCY COMPETENT OOCYTES
    • 由细胞表达的基因和使用相同的鉴定鉴定潜力的化学物质的测定
    • WO2013056258A1
    • 2013-04-18
    • PCT/US2012/060307
    • 2012-10-15
    • GEMA DIAGNOSTICS, INC.CIBELLI, Jose, B.IAGER, Amy, E.OTU, Hasan, H.
    • CIBELLI, Jose, B.IAGER, Amy, E.OTU, Hasan, H.
    • C12Q1/68C12Q1/02C12N5/075
    • C12Q1/6888C12Q1/6881C12Q2600/158
    • A genetic means of identifying "pregnancy competent" oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the "pregnancy signature", also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. In preferred embodiments the pregnancy signature will comprise one or more of FGF12, (Hs00374427_ml), GPR137B (Hs00162803_ml), SLC2A9 (Hs00417125_ml), ARID IB (Hs00368175_ml), NR2F6 (Hs00172870_ml), ZNF132 (Hs01036387_ml), FAM36A (Hs00831105_sl), ZNF93 (Hs01656246„sl), RHBDL2 (Hs00384848_ml), DNAJC15 (Hs00387763_ml), MTUS1 (Hs00826834_ml), ND NUP133 (Hs00217272_ml), or their orthologs, splice or allelic variants.
    • 提供鉴定“怀孕能力”卵母细胞的遗传方式。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 在优选实施方案中,怀孕签名将包括FGF12,(Hs00374427_ml),GPR137B(Hs00162803_ml),SLC2A9(Hs00417125_ml),ARID IB(Hs00368175_ml),NR2F6(Hs00172870_ml),ZNF132(Hs01036387_ml),FAM36A(Hs00831105_s1),ZNF93 (Hs01656246“sl),RHBDL2(Hs00384848_ml),DNAJC15(Hs00387763_ml),MTUS1(Hs00826834_ml),ND NUP133(Hs00217272_ml)或其直向同源物,剪接或等位基因变体。